Non-Radiographic Spondyloarthritis Has Greater Work Instability than Other Spondyloarthritis Subtypes in a National Database Sherry Rohekar 1, Robert D.

Slides:



Advertisements
Similar presentations
Psoriatic Arthritis: Creating a Model for Cost- Effectiveness Analysis GRAPPA meeting San Antonio, TX October 15, 2004 Supported by Schering Participants:
Advertisements

Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
Patients with Rheumatoid Arthritis in Comparison to Other Connective Tissue Diseases Are Mostly Influenced by Concomitant Fibromyalgia Tomš J, Daňková.
Table 1. Comparison between the provisional diagnosis based on the proforma versus final diagnosis Early arthritis Rheumatoid arthritis 3 6 Psoriatic.
STATISTICS David Pieper, Ph.D.
Effect of Staff Attitudes on Quality in Clinical Microbiology Services Ms. Julie Sims Laboratory Technical specialist Strengthening of Medical Laboratories.
Authors: Sujai M. Parker, Gunjan N. Jodi, Jalak Jani
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Background: Heart failure (HF) is an incurable life-long disease with poor prognosis. Symptoms such as dyspnea cause limitation in patients’ daily life.
Characterization of Self-reported Asthma in Morbidly Obese Women Observational studies have shown obesity to be associated with increased risk of asthma.
Comorbidity in SLE Compared with Rheumatoid Arthritis and Non-inflammatory Disorders Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4.
Multiple Choice Questions for discussion
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,
Rehabilitation Teaching and Research Unit, Wellington School of Medicine and Health Sciences Outcome measures in psoriatic arthritis Preliminary identification.
PsA: Review of Available Assessment Instruments and Lessons from Trial Results Part II Christian Antoni Friedrich Alexander University Erlangen-Nürnberg.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Quality of Life in People with and at Risk for Type 2 Diabetes: Findings from the Study to Help Improve Early Evaluation and Management of Risk Factors.
Fibromyalgia Patients Reading Self-Help Journals and in Internet Self-Help Groups: Are They Different from Patients in Clinical Practice? Robert Katz 1,
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
OMERACT 8 PsA Module Co-Chairs Dafna Gladman and Philip Mease Steering Committee Alice Gottlieb, Philip Helliwell, Arthur Kavanaugh, Gerry Krueger, Peter.
Psoriatic Arthritis Workshop OMERACT May 14 th, 2004 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heijde, Christian.
EFFICACY OF SPA THERAPY IN RHEUMATOID ARTHRITIS-A RANDOMISED CONTROLLED CLINICAL STUDY Mine Karagülle Department of Medical Ecology and Hydroclimatology.
Utilization Of Lipid-lowering Therapy In Hypertensive Patients In The United States Simon S.K. Tang, MPH* Sean Candrilli, MS** Lizheng Shi, PhD* *Department.
Assessment of enthesitis in psoriatic arthritis
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Advancing Knowledge to Improve Health Association of Care Coordination with Diabetes Outcome Measures among Adults with Diabetes David M. Mosen, PhD, MPH.
CORRELATION OF MSTS 87 & TESS FUNCTIONAL EVALUATION SCORES FOLLOWING ENDOPROSTHETIC REPLACEMENT FOR BONE SARCOMAS A Mahendra 1, AM Griffin 1, C Yu 1, Y.
DEVELOPEMENT OF A HOLISTC WELLNESS MODEL FOR MANAGERS IN TERTIARY INSTITUTIONS Petrus Albertus Botha Tshwane University of Technology Polokwane Delivery.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Comparison Between Community Pharmacists and General Practitioners Regarding the Symptomatic Management of Diarrhea and Dehydration in Children Presented.
Acute and Chronic Disability Among US Farmers and Pesticide Applicators: The National Health Interview Survey O Gómez-Marín, D Zheng, W LeBlanc, D Lee,
Normative misperceptions about alcohol use in the general population of drinkers Claire Garnett 1, David Crane 1, Robert West 2, Susan Michie 1, Jamie.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Group for Research and Assessment in Psoriasis and Psoriatic Artritis PGA/VAS Patient and Physician Perception of disease in Psoriatic Arthritis (3PPsA)
Master’s Essay in Epidemiology I P9419 Methods Luisa N. Borrell, DDS, PhD October 25, 2004.
OMERACT Workshop Outcome Measures in Psoriatic Arthritis
Do veterans with spinal cord injury and diabetes have greater risk of macrovascular complications? Ranjana Banerjea, PhD 1, Usha Sambamoorthi, PhD 1,2,3,
Conducted in the summer of 2012 at 19 COCA-I camps, with a total participation of 2725 campers.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Outcome Measures in PsA Philip Mease MD Seattle, WA.
GRAPPA Guidelines for PsA: Considerations GRAPPA Guidelines Mission Statement: “To develop guidelines, based upon the best scientific evidence, for the.
GRAPPA Committee Reports and Outcome measures Dafna D. Gladman, MD, FRCPC Professor of Medicine, University of Toronto Director, PsA Program, University.
Pediatric Resident Minimum Milestone Expectations by Level of Training Su-Ting Li, MD, MPH; Daniel Tancredi, PhD; Alan Schwartz, PhD; Ann Burke, MD; Ann.
PACE (Psoriatic Arthritis Costs Evaluation Study) (Psoriatic Arthritis Costs Evaluation Study)
The Natural History of Liver Fibrosis Progression Rate in Hepatitis C Infection David Yamini, Benjamin Basseri, Anush Arakelyan, Pedram Enayati, Tram T.
Introduction References Objectives Conclusions Results Faculty provision of performance feedback is critical for residents to improve their clinical skills.
Study Population In , 1,154 Mexican origin youth (aged years) indicated which of 50 movies (randomly selected from a pool of 250 popular movies.
ScWk 298 Quantitative Review Session
- Higher SBP visit-to-visit variability (SBV) has been associated
Disparities in process and outcome measures among adults with persistent asthma David M. Mosen, PhD, MPH; Michael Schatz, MD, MS; Rachel Gold, PhD; Winston.
Dr. Siti Nor Binti Yaacob
Patients were considered not in MDA (MDA−) with a score of 0, 1, 2, 3 or 4 points and in MDA (MDA+) with a score of 5, 6 or 7 points.
Development and Validation of HealthImpactTM: An Incident Diabetes Prediction Model Based on Administrative Data Rozalina G. McCoy, M.D.1, Vijay S. Nori,
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Comparison of the study findings: Male & female
Albarouni, Mohammed 1, Becker, Ingrid 2, Horneff, Gerd 1
Rhematoid Rthritis Respiratory disorders
David Pieper, Ph.D. STATISTICS David Pieper, Ph.D.
NURS 790: Methods for Research and Evidence Based Practice
Comorbidities in RA and PsA
Characteristics of Patients who Choose to Participate in a Comprehensive Medication Review (CMR) Program: Implication for Program Structure and Processes.
Univariate predictors of (A) ASDAS ID (<1
OR for baseline predictors of MDA at weeks 12, 24, 48, 96 and 144 by univariate analysis of observed data. OR for baseline predictors of MDA at weeks 12,
To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in Hidradenitis Suppurativa Alicia Pavon Blanco,1.
Health literacy – a new piece of the puzzle in psoriasis care?
Effect sizes (95% CI) of clinical variables per treatment group of studies directly comparing different dosages/routes. Effect sizes (95% CI) of clinical.
Multivariable model of adjusted
Public Health Implications
Presentation transcript:

Non-Radiographic Spondyloarthritis Has Greater Work Instability than Other Spondyloarthritis Subtypes in a National Database Sherry Rohekar 1, Robert D. Inman 2,Renise Ayearst 3, Proton Rahman 4, Walter Maksymowych 5, Dafna D. Gladman 2 1 Schulich School of Medicine and Dentistry, Western University, London, ON; 2 Toronto Western Research Institute, University Health Network, University of Toronto, Toronto ON; 3 Toronto Western Hospital, University of Toronto, Toronto ON; 4 Memorial University, St. John’s, NF; 5 University of Alberta, Edmonton AB Background Methods Objectives Results Conclusions Clinical subsets of spondyloarthrits (SpA) such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can have significantt impact on work performance and attendence Prior to becoming work disabled, patients’ functional abilities do not match their work demands This period of time is one of work instability (WI) To date, there have not been any large studies examining WI in SpA The Work Instability Scale for AS (AS-WIS) is a validated measure of work instability in a SpA population Determine the characteristics of WI in a large population of patients with SpA Identify risk factors for higher WI, such as disease type, demographic features, medication use and physical findings Determine correlations with commonly used outcome measures in SpA Strengths and Limitations Patients were recruited from two large, well established cohorts of SpA: the Spondyloarthritis Researech Consortium of Canada (SPARCC) and the International Psoriasis and Arthritis Research Team (IPART) WI was evaluated using a validated questionnaire, the AS-WIS Scores range from 0-20, with higher scores indicating greater WI Scores <11 are considered low risk for job loss Scores between are considered medium risk for job loss Scores between are considered at high risk for job loss Standard protocols were completed at the time of completion of the AS-WIS, including a detailed history, physical examination, physician-reported outcome measures and patient- reported outcome measures AS-WIS results were tabulated only on those who were currently employed Statistical analysis was performed using SPSS 20.0 and included basic descriptives, comparison of means, ANOVA, Pearson correlation, linear regression and multinomial regression 486 respondents 327 (67.3%) employed Location:  50.8% Toronto PsA clinic  46.5% Toronto AS clinic  2.8% London SpA clinic Gender:  69.7% male  30.3% female Disease Type:  52.0% PsA  39.8% AS  3.6% USpA  3.0% nXRSpA  0.9% ReA Drug Use:  59.0% NSAIDs  32.5% DMARDs  53.2% biologics Education Level:  59.3% university  25.4% college  12.8% high school graduate  2.1% high school incomplete  0.3% ≤ grade 8 Comorbid Conditions:  41.9% peripheral arthritis  41.3% PsO  31.6% concurrent illness (includes autoimmune, hyperlipidemia and liver disease)  19.8% heart  11.9% iritis  10.9% GI  5.2% GU  5.2% CNS  4.9% lung  3.0% diabetes Demographics CharacteristicMean Standard Deviation Age (years) Swollen Join Count (SJC) Tender Joint Count (TJC) Damaged Joint Count (DJC) Outcome MeasureMean Standard Deviation MD Global Assessment EQ5D DLQI HAQ FSS BAS-G BASDAI BASFI ASQoL FACIT SF-PCS SF-MCS Back Pain Patient Global Assessment Mean AS-WIS Score 6.8 (low risk). (SD 5.9, min. 0, max. 20) Demographics AS-WIS Score SignificantNon-Significant GI history Mean AS-WIS 6.6 (SD 5.7) vs 8.8 (SD 6.9); p=0.042 Iritis Peripheral arthritis, enthesitis or dactylitis Mean AS-WIS 6.0 (SD 5.6) vs. 8.0 (SD 6.1); p=0.003) Lung history Heart history GU history CNS history Psoriasis history Concurrent illness Diabetes AS-WIS and Education AS-WIS and Comorbidity AS-WIS and Disease Type AS-WIS and Medications Higher WI in NSAID (AS-WIS 7.9, SD 6.1) users vs. non-NSAID users (AS- WIS 5.2, SD 5.3), p< No difference between DMARD users and non-DMARD users. No difference between anti-TNF users and non-anti-TNF users. AS-WIS and Physical Exam No correlation between AS-WIS and swollen joint count. AS-WIS and tender joint count are correlated. Pearson correlation coefficient 0.17, p= No correlation between AS-WIS and total damaged joint count. Outcome Measure Pearson Correlation Coefficient MD Global Assessment0.43 EQ5D-0.42 DLQI0.40 HAQ0.53 FSS0.74 BAS-G0.68 BASDAI0.70 BASFI0.65 ASQoL0.79 FACIT-0.82 SF-PCS-0.71 SF-MCS-0.57 Back Pain Patient Global Assessment 0.59 AS-WIS and Outcome Measures Very good correlation between AS- WIS and all outcome measures. p< for each analysis. Linear Regression Linear regression was carried out using all significant variables from the simple analysis. Significant variables in the linear regression model were gender, education level, history of GI disease and history of NSAID use. Multinomial Logistic Regression Multinomial logistic regression was carried out using all significant variables from the linear regression. AS-WIS was categorized as low, medium and high risk. Reference category: Low Risk. Overall, WI was low (mean WIS 6.8, SD 5.9). nXRSpA had the most WI (mean WIS 10.2, SD 5.5). AS and nXRSpA had more WI than PsA. University educated patients had less WI. WI was greater in those who had a history of GI disease, peripheral arthritis and NSAID use. Commonly assessed outcome measures had significant correlation with AS-WIS. p =0.009 p =0.046p =0.027 p < p =0.017 Higher WI in AS vs. PsA. Higher WI in nXRSpA vs. PsA. Higher WI in high school incomplete vs. university. Higher WI in college vs. university. More WI in high school incomplete vs. high school grad. Strengths First large study of WI in a large, geographically diverse population of patients with SpA Limitations AS-WIS not validated in PsA Cross-sectional study design, so does not examine WI over time or predict future WI VariableExp(B) 95% CI for Exp(B) (lower, upper) Significance Medium Risk Gender , Education Level , GI History , Peripheral Arthritis , High Risk Gender , Education Level , GI History , Peripheral Arthritis , Significant variables for medium risk of WI: Education level GI history Peripheral arthritis history Significant variables fro high risk of WI: GI history nXRSpA had the highest level of WI (mean WIS 10.2, SD 5.5).